Akers Biosciences, Inc. FDA Inspection Record
Akers Biosciences, Inc. is an FDA-inspected facility (FEI 1000121922) located in Thorofare, NJ, US. RegDataLab tracks 4 FDA inspections and 1 compliance action at this facility.
What FDA found at this site
- Latest inspection
- Nov 4, 2015: No Action Indicated (NAI)
- Inspections on record
- 4 (1 OAI, 1 VAI, 2 NAI)
- Last OAI inspection
- May 9, 2011
- Warning letters
- 1 listed by FDA for this FEI, latest Oct 4, 2011
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Nov 4, 2015 | No Action Indicated (NAI) | No citations listed |
| Apr 11, 2012 | Voluntary Action Indicated (VAI) | Quality audits - Lack of or inadequate procedures (21 CFR 820.22) Lack of or inadequate procedures - Acceptance activities (21 CFR 820.80(a)) Management review - Lack of or inadequate procedures (21 CFR 820.20(c)) Lack of or inadequate process validation (21 CFR 820.75(a)) |
| May 9, 2011 | Official Action Indicated (OAI) | Design changes - Lack of or Inadequate Procedures (21 CFR 820.30(i)) Documentation of software validation (21 CFR 820.70(i)) Procedures for product review,disposition lack of/inadequate (21 CFR 820.90(b)(1)) |
| Apr 9, 2009 | No Action Indicated (NAI) | CAPA verification/validation of corrective/preventive action (21 CFR 820.100(a)(4)) General (21 CFR 820.198(a)) |
FDA record score
0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
3 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Apr 11, 2012 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | Oct 4, 2011 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | May 9, 2011 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Akers Biosciences, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Akers Biosciences, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Akers Biosciences, Inc.
- Location
- Thorofare, NJ (US)
- Source
- inspections